Remission of Postmenopausal Breast Cancer During Treatment With the Luteinising Hormone Releasing Hormone Agonist ICI 118630

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1986.260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Long Term Treatment With Luteinising Hormone Releasing Hormone Agonists and Maintenance of Serum Testosterone to Castration Concentrations.

BMJ
1985English

The Physiology of Growth Hormone-Releasing Hormone (GHRH) in Breast Cancer

2001English

Future Possibilities in the Prevention of Breast Cancer: Luteinizing Hormone-Releasing Hormone Agonists

Breast Cancer Research
Cancer ResearchOncology
2000English

Unusual Side Effect From a Luteinizing Hormone-Releasing Hormone Agonist, Leuprorelin, in the Treatment of Prostate Cancer: A Case Report

Journal of Medical Case Reports
Medicine
2016English

Cardioprotective Effects of Growth Hormone-Releasing Hormone Agonist After Myocardial Infarction

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Pulsatile Administration of Gonadotropin-Releasing Hormone Agonist to Gilts Actively Immunized Against Gonadotropin-Releasing Hormone

Journal of Animal Science
Animal ScienceZoologyGeneticsMedicineFood Science
1988English

Growth Hormone-Releasing Hormone as an Agonist of the Ghrelin Receptor GHS-R1a

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Pharmacological Response in Male Rats With Controlled Release Formulations of Luteinizing Hormone-Releasing Hormone Agonist

Polymer Journal
PolymersMaterials ChemistryPlastics
1986English

Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy